Compound Detail
CHEMBL1164729
FEBUXOSTAT 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1164729 |
| Name | FEBUXOSTAT |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | BQSJTQLCZDPROO-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
9
Targets
46
Activities
3
Assay Types
11
PK Parameters
20
Publications
8
Known Names
10
Indications
1
Mechanisms
Molecular Properties
316.4
MW (Da)
3.72
ALogP
5
HBA
1
HBD
83.2
PSA (Ų)
0.91
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2008 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Xanthine dehydrogenase inhibitor | INHIBITOR | Xanthine dehydrogenase/oxidase | ✓ | ✓ |
Indications
Arthritis, Gouty Gout Hyperuricemia Cardiovascular Diseases Tumor Lysis Syndrome Angina, Stable Hypertension Kidney Calculi Kidney Diseases Non-alcoholic Fatty Liver Disease
ATC Classification
M04AA03
febuxostat
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: ANTIGOUT PREPARATIONS
Drug Warnings
Black Box Warning
cardiotoxicity
Activity Summary
IC50 36 meas. best 8.9
Ki 8 meas. best 10.0
Kd 2 meas. best 5.79
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Xanthine dehydrogenase/oxidase CHEMBL1929 | Ki | 10.0 | 9.4325 | 0.1 | 4 |
| Xanthine dehydrogenase/oxidase CHEMBL3649 | Ki | 9.92 | 9.175 | 0.1 | 4 |
| Xanthine dehydrogenase/oxidase CHEMBL1929 | IC50 | 8.9 | 7.6182 | 1.3 | 11 |
| Xanthine dehydrogenase/oxidase CHEMBL3649 | IC50 | 8.56 | 7.9367 | 2.8 | 18 |
| Unchecked CHEMBL612545 | IC50 | 8.51 | 8.51 | 3.1 | 2 |
| Xanthine dehydrogenase/oxidase CHEMBL1075246 | IC50 | 8.4 | 8.4 | 4.0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 CHEMBL5393 | IC50 | 7.57 | 7.57 | 27.0 | 1 |
| Histone deacetylase 6 CHEMBL1865 | IC50 | 7.26 | 7.26 | 55.4 | 1 |
| Flavin reductase (NADPH) CHEMBL5019 | Kd | 5.79 | 5.79 | 1621.8 | 2 |
| ATP-binding cassette sub-family C member 4 CHEMBL1743128 | IC50 | 5.72 | 5.72 | 1900.0 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 4.37 | 4.37 | 42900.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 61510.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 7941.14 | ng.hr.mL-1 | Homo sapiens |
| AUC | 478018.54 | ng.hr.mL-1 | Sapajus apella |
| CL | 3.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 7.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 12.73 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| Cmax | 51741.58 | nM | Rattus norvegicus |
| T1/2 | 2.9 | hr | Rattus norvegicus |
| T1/2 | 2.9 | hr | Rattus norvegicus |
| T1/2 | 10.8 | hr | Homo sapiens |
| Tmax | 1.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine